Metabolic dysfunction in patients following DAA-induced viral cure for HCV infection: A non-negligible risk to liver-related health: Editorial on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C”
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Korean Association for the Study of the Liver
2025-04-01
|
| Series: | Clinical and Molecular Hepatology |
| Subjects: | |
| Online Access: | http://e-cmh.org/upload/pdf/cmh-2025-0155.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850196953366790144 |
|---|---|
| author | Chen-Hua Liu Yu-Ping Chang |
| author_facet | Chen-Hua Liu Yu-Ping Chang |
| author_sort | Chen-Hua Liu |
| collection | DOAJ |
| format | Article |
| id | doaj-art-fac8f543eb0a4a06b8217035e7a0889c |
| institution | OA Journals |
| issn | 2287-2728 2287-285X |
| language | English |
| publishDate | 2025-04-01 |
| publisher | Korean Association for the Study of the Liver |
| record_format | Article |
| series | Clinical and Molecular Hepatology |
| spelling | doaj-art-fac8f543eb0a4a06b8217035e7a0889c2025-08-20T02:13:19ZengKorean Association for the Study of the LiverClinical and Molecular Hepatology2287-27282287-285X2025-04-0131265866110.3350/cmh.2025.01552184Metabolic dysfunction in patients following DAA-induced viral cure for HCV infection: A non-negligible risk to liver-related health: Editorial on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C”Chen-Hua Liu0Yu-Ping Chang1 Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan Department of Internal Medicine, National Taiwan University Biomedical Park Hospital, Hsin-Chu, Taiwanhttp://e-cmh.org/upload/pdf/cmh-2025-0155.pdfhepatitis c virustype 2 diabetesdyslipidemialiver stiffness measurementfib-4 index |
| spellingShingle | Chen-Hua Liu Yu-Ping Chang Metabolic dysfunction in patients following DAA-induced viral cure for HCV infection: A non-negligible risk to liver-related health: Editorial on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C” Clinical and Molecular Hepatology hepatitis c virus type 2 diabetes dyslipidemia liver stiffness measurement fib-4 index |
| title | Metabolic dysfunction in patients following DAA-induced viral cure for HCV infection: A non-negligible risk to liver-related health: Editorial on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C” |
| title_full | Metabolic dysfunction in patients following DAA-induced viral cure for HCV infection: A non-negligible risk to liver-related health: Editorial on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C” |
| title_fullStr | Metabolic dysfunction in patients following DAA-induced viral cure for HCV infection: A non-negligible risk to liver-related health: Editorial on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C” |
| title_full_unstemmed | Metabolic dysfunction in patients following DAA-induced viral cure for HCV infection: A non-negligible risk to liver-related health: Editorial on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C” |
| title_short | Metabolic dysfunction in patients following DAA-induced viral cure for HCV infection: A non-negligible risk to liver-related health: Editorial on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C” |
| title_sort | metabolic dysfunction in patients following daa induced viral cure for hcv infection a non negligible risk to liver related health editorial on adverse impact of metabolic dysfunction on fibrosis regression following direct acting antiviral therapy a multicenter study for chronic hepatitis c |
| topic | hepatitis c virus type 2 diabetes dyslipidemia liver stiffness measurement fib-4 index |
| url | http://e-cmh.org/upload/pdf/cmh-2025-0155.pdf |
| work_keys_str_mv | AT chenhualiu metabolicdysfunctioninpatientsfollowingdaainducedviralcureforhcvinfectionanonnegligiblerisktoliverrelatedhealtheditorialonadverseimpactofmetabolicdysfunctiononfibrosisregressionfollowingdirectactingantiviraltherapyamulticenterstudyforchronichepatitisc AT yupingchang metabolicdysfunctioninpatientsfollowingdaainducedviralcureforhcvinfectionanonnegligiblerisktoliverrelatedhealtheditorialonadverseimpactofmetabolicdysfunctiononfibrosisregressionfollowingdirectactingantiviraltherapyamulticenterstudyforchronichepatitisc |